Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laszlo Vecsei

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|March 20, 2012
Should magnesium be given to every migraineur? NoArpad Pardutz, Laszlo Vecsei
CNS & Neurological Disorders Drug Targets|January 27, 2017
Monoamine Oxidase B Inhibitors in Parkinson's DiseaseLivia Dezsi, Laszlo Vecsei
European Journal of Clinical Pharmacology|October 17, 2009
Novel therapeutic strategies in Parkinson's diseasePeter Klivenyi, Laszlo Vecsei
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2011
Pharmacological models of Parkinson's disease in rodentsPeter Klivenyi, Laszlo Vecsei
CNS Neuroscience & Therapeutics|May 5, 2010
Pharmacological therapy in Parkinson's disease: focus on neuroprotectionZsigmond Tamas Kincses, Laszlo Vecsei
CNS & Neurological Disorders Drug Targets|October 11, 2016
Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: PimavanserinZsofia Majlath, Izabella Obal, Laszlo Vecsei
International Journal of Molecular Sciences|January 24, 2019
Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the KynureninesBernadett Fakan, Levente Szalardy, Laszlo Vecsei
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|December 28, 2012
Kynurenines in cognitive functions: their possible role in depressionImola Plangar, Zsofia Majlath, Laszlo Vecsei
Current Drug Targets|December 27, 2016
Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on LaquinimodZsofia Majlath, Adam Annus, Laszlo Vecsei
Expert Review of Clinical Pharmacology|September 5, 2012
Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases?Laszlo Vecsei, Imola Plangar, Levente Szalardy
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Neural Transmission (Vienna, Austria : 1996)|March 20, 2012
Should magnesium be given to every migraineur? NoArpad Pardutz, Laszlo Vecsei
CNS & Neurological Disorders Drug Targets|January 27, 2017
Monoamine Oxidase B Inhibitors in Parkinson's DiseaseLivia Dezsi, Laszlo Vecsei
European Journal of Clinical Pharmacology|October 17, 2009
Novel therapeutic strategies in Parkinson's diseasePeter Klivenyi, Laszlo Vecsei
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2011
Pharmacological models of Parkinson's disease in rodentsPeter Klivenyi, Laszlo Vecsei
CNS Neuroscience & Therapeutics|May 5, 2010
Pharmacological therapy in Parkinson's disease: focus on neuroprotectionZsigmond Tamas Kincses, Laszlo Vecsei
CNS & Neurological Disorders Drug Targets|October 11, 2016
Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: PimavanserinZsofia Majlath, Izabella Obal, Laszlo Vecsei
International Journal of Molecular Sciences|January 24, 2019
Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the KynureninesBernadett Fakan, Levente Szalardy, Laszlo Vecsei
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|December 28, 2012
Kynurenines in cognitive functions: their possible role in depressionImola Plangar, Zsofia Majlath, Laszlo Vecsei
Current Drug Targets|December 27, 2016
Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on LaquinimodZsofia Majlath, Adam Annus, Laszlo Vecsei
Expert Review of Clinical Pharmacology|September 5, 2012
Manipulation with kynurenines: a possible tool for treating neurodegenerative diseases?Laszlo Vecsei, Imola Plangar, Levente Szalardy
Pageof 7